DK1699468T3 - Farmaceutisk sammensætning, der omfatter et zink-hyaluronatkompleks, til behandling af dissemineret skelrose - Google Patents
Farmaceutisk sammensætning, der omfatter et zink-hyaluronatkompleks, til behandling af dissemineret skelroseInfo
- Publication number
- DK1699468T3 DK1699468T3 DK04798745T DK04798745T DK1699468T3 DK 1699468 T3 DK1699468 T3 DK 1699468T3 DK 04798745 T DK04798745 T DK 04798745T DK 04798745 T DK04798745 T DK 04798745T DK 1699468 T3 DK1699468 T3 DK 1699468T3
- Authority
- DK
- Denmark
- Prior art keywords
- treatment
- disseminated
- skeletal
- rose
- pharmaceutical composition
- Prior art date
Links
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 3
- 241000220317 Rosa Species 0.000 title 1
- VJVOFLWZDWLHNR-MRCUWXFGSA-N icosan-9-yl (z)-docos-13-enoate Chemical compound CCCCCCCCCCCC(CCCCCCCC)OC(=O)CCCCCCCCCCC\C=C/CCCCCCCC VJVOFLWZDWLHNR-MRCUWXFGSA-N 0.000 title 1
- 229940099552 hyaluronan Drugs 0.000 abstract 2
- 229920002674 hyaluronan Polymers 0.000 abstract 2
- 201000006417 multiple sclerosis Diseases 0.000 abstract 2
- 239000004480 active ingredient Substances 0.000 abstract 1
- 239000000654 additive Substances 0.000 abstract 1
- 230000000996 additive effect Effects 0.000 abstract 1
- 239000003937 drug carrier Substances 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 230000001225 therapeutic effect Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
- A61K31/728—Hyaluronic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/30—Zinc; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Neurosurgery (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurology (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Dermatology (AREA)
- Inorganic Chemistry (AREA)
- Molecular Biology (AREA)
- Psychology (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| HU0303779A HUP0303779A2 (en) | 2003-11-20 | 2003-11-20 | Pharmaceutical compositions containing hyaluronan complex for the treatment of sclerosis multiplex |
| PCT/HU2004/000107 WO2005049047A1 (en) | 2003-11-20 | 2004-11-18 | Pharmaceutical composition comprising a zinc-hyaluronate complex for the treatment of multiple sclerosis |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK1699468T3 true DK1699468T3 (da) | 2007-09-03 |
Family
ID=90001707
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK04798745T DK1699468T3 (da) | 2003-11-20 | 2004-11-18 | Farmaceutisk sammensætning, der omfatter et zink-hyaluronatkompleks, til behandling af dissemineret skelrose |
Country Status (19)
| Country | Link |
|---|---|
| US (1) | US20070123488A1 (da) |
| EP (1) | EP1699468B1 (da) |
| JP (1) | JP4778908B2 (da) |
| CN (1) | CN1882352B (da) |
| AT (1) | ATE359800T1 (da) |
| CY (1) | CY1106617T1 (da) |
| DE (1) | DE602004006024T2 (da) |
| DK (1) | DK1699468T3 (da) |
| EA (1) | EA009209B1 (da) |
| ES (1) | ES2286698T3 (da) |
| HR (1) | HRP20070291T3 (da) |
| HU (1) | HUP0303779A2 (da) |
| NO (1) | NO336121B1 (da) |
| PL (1) | PL1699468T3 (da) |
| PT (1) | PT1699468E (da) |
| RS (2) | RS20060325A (da) |
| SI (1) | SI1699468T1 (da) |
| UA (1) | UA83516C2 (da) |
| WO (1) | WO2005049047A1 (da) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20070099867A1 (en) * | 2005-05-24 | 2007-05-03 | Glycoscience Laboratories, Inc. | Pharmaceutical agent containing hyaluronan as an active ingredient |
| JP2007153761A (ja) * | 2005-12-01 | 2007-06-21 | Toshitsu Kagaku Kenkyusho:Kk | シナプス伝達促進剤及びシナプス保護剤 |
| RU2342148C2 (ru) * | 2005-09-26 | 2008-12-27 | Гликосайенс Лабораториз, Инк. | Фармацевтическое средство, содержащее гиалуронан в качестве активного ингредиента |
| JP2009091248A (ja) * | 2006-01-17 | 2009-04-30 | Toshitsu Kagaku Kenkyusho:Kk | 外傷性神経障害および／または運動機能障害の治療薬 |
| BRPI0621470A2 (pt) | 2006-12-05 | 2011-12-13 | Glycoscience Lab Inc | agente terapêutico para artrite degenerativa |
| JP2007277258A (ja) * | 2007-06-20 | 2007-10-25 | Toshitsu Kagaku Kenkyusho:Kk | 炎症及び神経疾患の治療剤及び予防剤 |
| DK2630962T3 (da) * | 2009-08-20 | 2018-07-23 | Yeda Res & Development Company Ltd | Lavfrekvent glatiramer-acetat-terapi |
| CN111647100B (zh) * | 2020-07-14 | 2022-03-01 | 山东华熙海御生物医药有限公司 | 一种高分子量透明质酸锌的制备方法 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| HU203372B (en) * | 1989-02-24 | 1991-07-29 | Richter Gedeon Vegyeszet | Process for producing hyaluronic associates and pharmaceutical compositions and cosmetics comprising such active ingredient |
| AU719365B2 (en) * | 1995-09-28 | 2000-05-04 | Sangstat Medical Corporation | Use of hyaluronic acid as an immunosuppressant |
| HU225991B1 (en) * | 1997-04-29 | 2008-02-28 | Richter Gedeon Nyrt | Use of the zinc hyaluronate associate (complex) for the preparation of pharmaceutical compositions for oral use against peptic ulcer |
| DE19721099C2 (de) * | 1997-05-20 | 1999-12-02 | Fumapharm Ag Muri | Verwendung von Fumarsäurederivaten |
| JP2003089647A (ja) * | 1999-03-10 | 2003-03-28 | Takada Seiyaku Kk | 関節性疾患治療剤 |
| JP2001163789A (ja) * | 1999-12-13 | 2001-06-19 | Maruho Co Ltd | マトリックスメタロプロテアーゼ阻害用医薬組成物 |
| BG104880A (en) * | 2000-10-24 | 2002-04-30 | Иван ХРИСТОВ | Medicamentous preparation for multiple sclerosis treatment |
| WO2002074318A1 (fr) * | 2001-03-15 | 2002-09-26 | Seikagaku Corporation | Agents de regulation d'expression d'il-12 |
-
2003
- 2003-11-20 HU HU0303779A patent/HUP0303779A2/hu unknown
-
2004
- 2004-11-18 RS YUP-2006/0325A patent/RS20060325A/sr unknown
- 2004-11-18 WO PCT/HU2004/000107 patent/WO2005049047A1/en not_active Ceased
- 2004-11-18 PT PT04798745T patent/PT1699468E/pt unknown
- 2004-11-18 JP JP2006540634A patent/JP4778908B2/ja not_active Expired - Fee Related
- 2004-11-18 EP EP04798745A patent/EP1699468B1/en not_active Expired - Lifetime
- 2004-11-18 DE DE602004006024T patent/DE602004006024T2/de not_active Expired - Lifetime
- 2004-11-18 SI SI200430325T patent/SI1699468T1/sl unknown
- 2004-11-18 HR HR20070291T patent/HRP20070291T3/xx unknown
- 2004-11-18 RS RSP-2007/0270A patent/RS50523B/sr unknown
- 2004-11-18 CN CN200480034039XA patent/CN1882352B/zh not_active Expired - Fee Related
- 2004-11-18 DK DK04798745T patent/DK1699468T3/da active
- 2004-11-18 US US10/579,256 patent/US20070123488A1/en not_active Abandoned
- 2004-11-18 ES ES04798745T patent/ES2286698T3/es not_active Expired - Lifetime
- 2004-11-18 UA UAA200606730A patent/UA83516C2/uk unknown
- 2004-11-18 EA EA200600998A patent/EA009209B1/ru not_active IP Right Cessation
- 2004-11-18 PL PL04798745T patent/PL1699468T3/pl unknown
- 2004-11-18 AT AT04798745T patent/ATE359800T1/de active
-
2006
- 2006-06-19 NO NO20062857A patent/NO336121B1/no not_active IP Right Cessation
-
2007
- 2007-05-23 CY CY20071100698T patent/CY1106617T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| HK1098352A1 (en) | 2007-07-20 |
| PT1699468E (pt) | 2007-06-05 |
| RS50523B (sr) | 2010-05-07 |
| UA83516C2 (uk) | 2008-07-25 |
| CY1106617T1 (el) | 2012-01-25 |
| HRP20070291T3 (hr) | 2007-10-31 |
| EA009209B1 (ru) | 2007-12-28 |
| DE602004006024T2 (de) | 2007-12-27 |
| ATE359800T1 (de) | 2007-05-15 |
| PL1699468T3 (pl) | 2007-09-28 |
| EA200600998A1 (ru) | 2006-10-27 |
| NO336121B1 (no) | 2015-05-18 |
| SI1699468T1 (sl) | 2007-08-31 |
| EP1699468B1 (en) | 2007-04-18 |
| JP2007512311A (ja) | 2007-05-17 |
| US20070123488A1 (en) | 2007-05-31 |
| WO2005049047A1 (en) | 2005-06-02 |
| HUP0303779A2 (en) | 2006-02-28 |
| CN1882352A (zh) | 2006-12-20 |
| JP4778908B2 (ja) | 2011-09-21 |
| DE602004006024D1 (de) | 2007-05-31 |
| NO20062857L (no) | 2006-08-18 |
| HUP0303779D0 (en) | 2004-03-01 |
| RS20060325A (sr) | 2008-08-07 |
| CN1882352B (zh) | 2010-08-04 |
| ES2286698T3 (es) | 2007-12-01 |
| EP1699468A1 (en) | 2006-09-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| WO2005004818A3 (en) | Heterocyclic compounds and their use as anticancer agents | |
| UA86063C2 (ru) | Липосомы для снабжения лекарств | |
| IS8502A (is) | Azatvíhringja heteróhringir sem kannabínóíð-viðtakastillar | |
| IS8503A (is) | Azatvíhringja heteróhringir sem kannabínóníð-viðtakastillar | |
| GB0022438D0 (en) | Organic Compounds | |
| MY143795A (en) | Tetrahydropyridoindole derivatives | |
| ATE493412T1 (de) | Spirohydantoin-aryl-cgrp-rezeptorantagonisten | |
| DK1696905T3 (da) | Substituerede 2-aminotetraliner til forebyggende behandling af Morbus Parkinson | |
| ATE487720T1 (de) | 5,6,7,8-tetrahydropteridin-derivate als hsp90- hemmer | |
| TW200611695A (en) | Pyrrolopyridine derivatives | |
| ATE411296T1 (de) | Imidazolinderivate mit cb1-antagonistischer wirkung | |
| CY1106617T1 (el) | Φαρμακευτικη συνθεση περιλαμβανουσα συμπλοκο ψευδαργυρου-υαλουρονικου για τη θεραπεια σκληρυνσης κατα πλακας | |
| EA200500871A1 (ru) | Пептиды, ингибирующие ангиогенез, миграцию клеток, инвазию клеток и пролиферацию клеток, композиции и их применение | |
| TW200626158A (en) | Naphthaline derivatives | |
| TW200731975A (en) | Novel combinations of medicaments for the treatment of respiratory diseases | |
| DK1638582T3 (da) | Anvendelse af hyaluronsyre til fremstilling af kompositioner til behandling af tilbagevendende after | |
| MX2007007027A (es) | Derivados piperazinilpiridina como agentes anti-obesidad. | |
| TW200603727A (en) | Facially amphiphilic polyaryl and polyarylalkynyl polymers and oligomers and uses thereof | |
| TW200503703A (en) | Pharmaceutical compositions | |
| ATE442864T1 (de) | Pharmazeutische zusammensetzung mit einem organopolysiloxan-elastomer und einem lösungsmittel-aktivwirkstoff | |
| MXPA05007495A (es) | Tienopiridazinonas y su uso en la modulacion de enfermedades autoinmunes. | |
| BRPI0507811A (pt) | derivados de 7h-pirrolopirimidina | |
| UY27311A1 (es) | Agentes antibacterianos | |
| WO2006004903A3 (en) | 1,2-bis-(substituted-phenyl)-2-propen-1-ones and pharmaceutical compositions thereof | |
| WO2004108094A3 (en) | Sulfonamide-substituted chalcone derivatives and their use to treat diseases |